Use of Sodium-glucose Cotransporter 2 Inhibitors in Patients with Chronic Kidney Disease
{{output}}
Chronic kidney disease (CKD) is a common complication in patients with diabetes mellitus. Recently, the class of sodium-glucose cotransporter 2 inhibitors (SGLT2-Is) has been shown to have cardiovascular and renal benefits. The extent of the use of SGLT2-Is in... ...
